A clinical trial to study the comparative effectiveness of Haritaki as a single drug & Haritaki with eye exercises in management of Timir with reference to simple myopia.

Phase 3

Not yet recruiting

• Conditions: Other specified disorders of eye and adnexa. Ayurveda Condition: TIMIRAH, (2) ICD-10 Condition: H578||Other specified disorders of eye and adnexa. Ayurveda Condition: TIMIRAH,

• Registration Number: CTRI/2023/08/056223
• Lead Sponsor: Dr. Madhura Shardul Bapat

Brief Summary

This  is   two  group  comparative  study  to   evaluate the  efficacy  of  Haritaki   (1gm  along  with 8-10  mrudvika and water  as  anupan  at  morning  )  (group  1  -  50 patients ) as  single drug  and   Haritaki (1gm  along  with   8-10  mrudvika and water  as  anupan  at  morning  )with  eye exercises(15-20 min  daily)   (group 2  -  50 patients)   for   40  days  .Primary  outcome  is  to  study  the  effectiveness of  Haritaki  as  single  drug  in  management  of Timir .Secondary  outcome   is   to find  out the role  of  Haritaki  as single drug  along with  Mrudvika  on  sign and  symptoms  of    Timir.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-08
• Last Update Posted: 2023-11-07

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• 1)Patients between age group 18-25 yrs 2)Classical symptoms of Timir /pratham patalgat vikar 3)Patients with Spherical refractive error.
• 4)Refractive errors upto (-0.50 D) to (-3 D).

Exclusion Criteria

• 1)Patients with ocular dises like Glaucoma ,Retinal detachment or systemic diseases like type ii DM ,Asthama ,Hypo /hyper thyroidism 2)Patients having extra ocular & intra ocular infections like conjunctivitis,Blepharitis and Dacryocystitis 3)Patients having corneal ulcers 4)Patients after surgeries like photorefractive keratotomy,post-traumatic or congenital cataract surgery ,Radial keratotomy ,LASIK etc...
• 5)Patients practcing pranayama or daily exercises 6)Refractive errors more than -3D.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the effectiveness of Haritaki in management of Avyakt Darshan (blurring ),Headache ,Eyepain ,Redness ,Visual acuity .	40 days

Secondary Outcome Measures

Name	Time	Method
To compare the effectiveness of Haritaki as a single drug & Haritaki with eye exercises in management of Avyakt Darshan (blurring) ,Headache ,Eye pain & visual acuity

Trial Locations

Locations (1)

AVPMS Ayurved Mahavidyalaya Sion; 🇮🇳 Mumbai, MAHARASHTRA, India

AVPMS Ayurved Mahavidyalaya Sion

🇮🇳Mumbai, MAHARASHTRA, India

DrMadhura Bapat

Principal investigator

9970772299

madhurabapat18@gmail.com